US stocks drop as oil hits new multi-year low | Inquirer Business

US stocks drop as oil hits new multi-year low

/ 06:25 AM January 13, 2015

Specialist Charles Boeddinghaus, right, works with traders on the floor of the New York Stock Exchange Monday, Jan. 12, 2015. US stocks opened Monday a busy week of corporate earnings sharply lower as oil prices slumped to fresh multi-year lows.  AP PHOTO/RICHARD DREW

Specialist Charles Boeddinghaus, right, works with traders on the floor of the New York Stock Exchange Monday, Jan. 12, 2015. US stocks opened Monday a busy week of corporate earnings sharply lower as oil prices slumped to fresh multi-year lows. AP PHOTO/RICHARD DREW

NEW YORK–US stocks on Monday opened a busy week of corporate earnings sharply lower as oil prices slumped to fresh multi-year lows.

The Dow Jones Industrial Average dropped 96.53 points (0.54 percent) to 17,640.84.

Article continues after this advertisement

The broad-based S&P 500 sank 16.55 (0.81 percent) to 2,028.26, while the tech-rich Nasdaq Composite Index tumbled 39.36 (0.84 percent) to 4,664.71.

FEATURED STORIES

European benchmark Brent oil closed below $50 a barrel for the first time since April 2009 following a gloomy petroleum-market forecast from Goldman Sachs.

Energy equities fell sharply, including Dow member Chevron and Marathon Oil, by 2.2 percent and 5.1 percent, respectively.

Article continues after this advertisement

“The market is nervous about lower energy prices and whether they are forecasting a slowdown in global economic growth, and not just a supply-demand imbalance,” said Sam Stovall, chief investment strategist at S&P Capital IQ.

Article continues after this advertisement

NPS Pharmaceuticals bolted 8.2 percent higher after announcing plans to be bought by Ireland-based Shire for $5.2 billion.

Article continues after this advertisement

Animal-health company MWI Veterinary Supply gained 8.2 percent on news it will be acquired by pharmaceutical distributor AmerisourceBergen for $2.5 billion. AmerisourceBergen lost 2.2 percent.

Drugmaker Bristol-Myers Squibb advanced 3.1 percent on news that a study for its Opdivo lung cancer drug was stopped because an independent panel found that the medicine succeeded in improving survival rates in patients.

Article continues after this advertisement

Biotech company Celgene tacked on 2.9 percent as it projected 2015 sales of $9-$9.5 billion, a 22 percent increase from last year.

Jewelry chain Tiffany slumped 14.0 percent as it said sales during the key holiday period fell one percent from last year, with an especially weak performance in Japan. Chief Michael Kowalski characterized the results as “disappointing overall.”

SanDisk, which manufacturers data storage products in consumer electronics, lost 13.9 percent after announcing that it expects fourth-quarter sales of $1.73 billion, down from a previous forecast for $1.80-$1.85 billion.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Bond prices rose. The yield on the 10-year US Treasury fell to 1.91 percent from 1.96 percent Friday, while the 30-year declined to 2.49 percent from 2.54 percent. Bond prices and yields move inversely.

TAGS: bond prices, Finance, Stock Activity, stocks, US

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.